A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
Trial details
- Registry ID
- NCT04800562
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis LipoidicaNCT04800562 | Processa Pharmaceuticals | Phase 2 | Terminated | 2023-02-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |